BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22845054)

  • 1. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse.
    Rice JB; White AG; Birnbaum HG; Schiller M; Brown DA; Roland CL
    Pain Med; 2012 Sep; 13(9):1162-73. PubMed ID: 22845054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic models to identify patients at risk for prescription opioid abuse.
    White AG; Birnbaum HG; Schiller M; Tang J; Katz NP
    Am J Manag Care; 2009 Dec; 15(12):897-906. PubMed ID: 20001171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sources of prescription opioids among diagnosed opioid abusers.
    Shei A; Rice JB; Kirson NY; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Curr Med Res Opin; 2015 Apr; 31(4):779-84. PubMed ID: 25661018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.
    Kirson NY; Shei A; Rice JB; Enloe CJ; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Pain Med; 2015 Jul; 16(7):1325-32. PubMed ID: 25929289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
    Davis JM; Severtson SG; Bucher-Bartelson B; Dart RC
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):18-25. PubMed ID: 24130046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for potential prescription opioid misuse in a michigan medicaid population.
    Braker LS; Reese AE; Card RO; Van Howe RS
    Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and non-medical use of prescription opioids: results from a national US survey.
    Tetrault JM; Desai RA; Becker WC; Fiellin DA; Concato J; Sullivan LE
    Addiction; 2008 Feb; 103(2):258-68. PubMed ID: 18042194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tool to Assess Risk of De Novo Opioid Abuse or Dependence.
    Ciesielski T; Iyengar R; Bothra A; Tomala D; Cislo G; Gage BF
    Am J Med; 2016 Jul; 129(7):699-705.e4. PubMed ID: 26968469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of opioid abuse and misuse determined from a Medicaid database.
    McAdam-Marx C; Roland CL; Cleveland J; Oderda GM
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):5-18. PubMed ID: 20345194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use.
    Coutinho AD; Gandhi K; Fuldeore RM; Landsman-Blumberg PB; Gandhi S
    J Opioid Manag; 2018; 14(2):131-141. PubMed ID: 29733099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
    Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
    Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation.
    Butler SF; Black R; Grimes Serrano JM; Folensbee L; Chang A; Katz N
    Pain Med; 2010 Jan; 11(1):81-91. PubMed ID: 20002324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring attractiveness for abuse of prescription opioids.
    Butler SF; Fernandez KC; Chang A; Benoit C; Morey LC; Black R; Katz N
    Pain Med; 2010 Jan; 11(1):67-80. PubMed ID: 20002325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with nonmedical use of prescription opioids among heroin-abusing research volunteers.
    Steinmiller CL; Greenwald M
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):492-500. PubMed ID: 17924783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
    Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
    Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.
    Cepeda MS; Fife D; Ma Q; Ryan PB
    J Pain; 2013 Oct; 14(10):1227-41. PubMed ID: 23850177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.